8-KOther EventsExhibits & Filings

CVS HEALTH Corp 8-K Report, Corporate Update (Dec 3, 2010)

Filed December 3, 2010For Securities:CVS

Summary

CVS Caremark Corporation (now CVS Health) announced on December 3, 2010, the appointment of Hank Mullany as Executive Vice President and President of CVS/pharmacy. Mr. Mullany's extensive experience includes his prior role as Executive Vice President of Wal-Mart Stores, Inc. and President of Walmart North, overseeing a significant portion of Walmart's U.S. retail operations. This appointment is notable as it comes amidst a lawsuit filed by Walmart, alleging that Mr. Mullany's non-competition agreement with them prohibits him from joining CVS Caremark. Both CVS Caremark and Mr. Mullany maintain that the lawsuit's claims are unfounded and intend to vigorously defend against Walmart's legal challenge. Investors should monitor the outcome of this litigation as it could potentially impact the integration and leadership of the CVS/pharmacy division.

Key Highlights

  • 1CVS Caremark announced the hiring of Hank Mullany as Executive Vice President and President of CVS/pharmacy, effective December 6, 2010.
  • 2Mr. Mullany previously served as Executive Vice President of Wal-Mart Stores, Inc. and President of Walmart North, managing 1,300 stores.
  • 3Walmart has filed a lawsuit alleging Mr. Mullany's non-competition agreement with them is violated by his new role at CVS Caremark.
  • 4CVS Caremark and Mr. Mullany believe Walmart's lawsuit lacks merit and intend to defend it aggressively.
  • 5The company's press release regarding this appointment is attached as an exhibit to the 8-K filing.

Frequently Asked Questions

Hank Mullany has been hired as Executive Vice President of CVS Caremark Corporation and President of CVS/pharmacy. He brings significant retail leadership experience from his previous role at Walmart.

Walmart has sued CVS Caremark and Hank Mullany, alleging that Mr. Mullany's employment with CVS Caremark violates a non-competition agreement he had with Walmart.

CVS Caremark and Mr. Mullany believe the lawsuit filed by Walmart is without merit and intend to defend against the allegations vigorously.

The primary risk for investors is the potential disruption to the leadership of the CVS/pharmacy division and the legal costs associated with defending the lawsuit. The outcome of the litigation could affect Mr. Mullany's ability to fully perform his duties.